195 related articles for article (PubMed ID: 20864298)
1. A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model.
Lopes LB; Brophy CM; Flynn CR; Yi Z; Bowen BP; Smoke C; Seal B; Panitch A; Komalavilas P
J Vasc Surg; 2010 Dec; 52(6):1596-607. PubMed ID: 20864298
[TBL] [Abstract][Full Text] [Related]
2. MK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasia.
Evans BC; Hocking KM; Osgood MJ; Voskresensky I; Dmowska J; Kilchrist KV; Brophy CM; Duvall CL
Sci Transl Med; 2015 Jun; 7(291):291ra95. PubMed ID: 26062847
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HSP27 phosphorylation by a cell-permeant MAPKAP Kinase 2 inhibitor.
Lopes LB; Flynn C; Komalavilas P; Panitch A; Brophy CM; Seal BL
Biochem Biophys Res Commun; 2009 May; 382(3):535-9. PubMed ID: 19289101
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo.
Muto A; Panitch A; Kim N; Park K; Komalavilas P; Brophy CM; Dardik A
Vascul Pharmacol; 2012; 56(1-2):47-55. PubMed ID: 22024359
[TBL] [Abstract][Full Text] [Related]
5. Transduction of peptide analogs of the small heat shock-related protein HSP20 inhibits intimal hyperplasia.
Tessier DJ; Komalavilas P; Liu B; Kent CK; Thresher JS; Dreiza CM; Panitch A; Joshi L; Furnish E; Stone W; Fowl R; Brophy CM
J Vasc Surg; 2004 Jul; 40(1):106-14. PubMed ID: 15218470
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic MK2 inhibition blocks pathological vascular smooth muscle cell phenotype switch.
Tierney JW; Evans BC; Cheung-Flynn J; Wang B; Colazo JM; Polcz ME; Cook RS; Brophy CM; Duvall CL
JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34622803
[TBL] [Abstract][Full Text] [Related]
7. Heparin-functionalized polymer graft surface eluting MK2 inhibitory peptide to improve hemocompatibility and anti-neointimal activity.
Lee Y; Le Thi P; Seon GM; Ryu SB; Brophy CM; Kim Y; Park JC; Park KD; Cheung-Flynn J; Sung HJ
J Control Release; 2017 Nov; 266():321-330. PubMed ID: 28987880
[TBL] [Abstract][Full Text] [Related]
8. Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia.
Déglise S; Martin D; Probst H; Saucy F; Hayoz D; Waeber G; Nicod P; Ris HB; Corpataux JM; Haefliger JA
J Vasc Surg; 2005 Jun; 41(6):1043-52. PubMed ID: 15944608
[TBL] [Abstract][Full Text] [Related]
9. Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia.
Osgood MJ; Sexton K; Voskresensky I; Hocking K; Song J; Komalavilas P; Brophy C; Cheung-Flynn J
J Vasc Surg; 2016 Aug; 64(2):471-478. PubMed ID: 27763268
[TBL] [Abstract][Full Text] [Related]
10. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of the 27-kDa heat shock protein via p38 MAP kinase and MAPKAP kinase in smooth muscle.
Larsen JK; Yamboliev IA; Weber LA; Gerthoffer WT
Am J Physiol; 1997 Nov; 273(5):L930-40. PubMed ID: 9374719
[TBL] [Abstract][Full Text] [Related]
12. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Petrofski JA; Hata JA; Williams ML; Parsa CJ; Thompson RB; Hanish SI; Gehrig TR; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1683-90. PubMed ID: 16308016
[TBL] [Abstract][Full Text] [Related]
13. p38 MAPK inhibitor, CBS3830 limits vascular remodelling in arterialised vein grafts.
Ge JJ; Zhao ZW; Zhou ZC; Wu S; Zhang R; Pan FM; Abendroth DK
Heart Lung Circ; 2013 Sep; 22(9):751-8. PubMed ID: 23523564
[TBL] [Abstract][Full Text] [Related]
14. p38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle.
Meloche S; Landry J; Huot J; Houle F; Marceau F; Giasson E
Am J Physiol Heart Circ Physiol; 2000 Aug; 279(2):H741-51. PubMed ID: 10924074
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein 27 is a substrate of cGMP-dependent protein kinase in intact human platelets: phosphorylation-induced actin polymerization caused by HSP27 mutants.
Butt E; Immler D; Meyer HE; Kotlyarov A; Laass K; Gaestel M
J Biol Chem; 2001 Mar; 276(10):7108-13. PubMed ID: 11383510
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation status of heat shock protein 27 plays a key role in gemcitabine-induced apoptosis of pancreatic cancer cells.
Nakashima M; Adachi S; Yasuda I; Yamauchi T; Kawaguchi J; Itani M; Yoshioka T; Matsushima-Nishiwaki R; Hirose Y; Kozawa O; Moriwaki H
Cancer Lett; 2011 Dec; 313(2):218-25. PubMed ID: 21999932
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cell-matrix contacts and beta-catenin signaling in VSMC by integrin-linked kinase: implications for intimal thickening.
Dwivedi A; Sala-Newby GB; George SJ
Basic Res Cardiol; 2008 May; 103(3):244-56. PubMed ID: 18080083
[TBL] [Abstract][Full Text] [Related]
18. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
19. Oral intake of hydrogen-rich water inhibits intimal hyperplasia in arterialized vein grafts in rats.
Sun Q; Kawamura T; Masutani K; Peng X; Sun Q; Stolz DB; Pribis JP; Billiar TR; Sun X; Bermudez CA; Toyoda Y; Nakao A
Cardiovasc Res; 2012 Apr; 94(1):144-53. PubMed ID: 22287575
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of N-cadherin retards smooth muscle cell migration and intimal thickening via induction of apoptosis.
Lyon CA; Koutsouki E; Aguilera CM; Blaschuk OW; George SJ
J Vasc Surg; 2010 Nov; 52(5):1301-9. PubMed ID: 20630685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
